Communicable Disease Control Branch
Communicable Disease Management Protocol – Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS), February 2010
Legislative and Policy analysis and recommendations for reform
European Scientific Journal, November edition vol. 8, No.26 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431
Accessed: 29.09.2019
Single TB and HIV Concept Note Albania 2016-2018 27 April 2015
Evaluation report November 2014
Endorsed by the CCM Georgia on April 15th 2015
Accessed: 26.09.2019
China and Eurasia Forum Quarterly, Volume 6, No. 3 (2008) p. 101-128 © Central Asia-Caucasus Institute & Silk Road Studies Program
ISSN: 1653-4212
Mission report April 2016
PLOS ONE | https://doi.org/10.1371/journal.pone.0203986 October 3, 2018
UNAIDS/10.03E / JC1767E (English original, March 2010) ISBN 978 92 9 173849 6
PQDx 0198-071-00
WHO PQDx PR
April/2016, version 2.0
3rd Edition – July 2017
www.msfaccess.org
The following protocol has been designed to investigate the extent of infection, as determined by seropositivity in the general population, in any country in which COVID-19 virus infection has been reported. Each country may need to tailor some aspects of this protocol to align with public health, l...aboratory and clinical systems, according to capacity, availability of resources and cultural appropriateness. However, using a standardized protocol such as this one below, epidemiological exposure data and biological samples can be systematically collected and shared rapidly in a format that can be easily aggregated, tabulated and analyzed across many different settings globally for timely estimates of COVID-19 virus infection severity and attack rates, as well as to inform public health responses and policy decisions. This is particularly important in the context of a novel respiratory pathogen, such as COVID-19 virus
more